PAR-24-022 - Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications |
NOT-EB-23-022 |
NIBIB , NCATS , NCI , NEI , NHLBI , NIGMS
|
Dec 13, 2023 |
Jan 27, 2027
|
R35, RM1, R21, R01, U01, R15, R13, K99/R00 |
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. |
NOT-EB-23-002 |
NIBIB , NCCIH , NCI , NHLBI , NIA , NIAID , NICHD , NIGMS
|
Apr 14, 2023 |
May 17, 2026
|
R01, R21, R35, R41/R42, R43/R44 |
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging |
NOT-EB-22-006 |
NIBIB
|
Mar 21, 2022 |
May 8, 2024
|
R21, F30, K01, R13, K23, K25, R43/R44, K08, R01, K99/R00, R41/R42, F32, R03, F31 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition |
NOT-HD-21-027 |
NICHD NIAAA NCI NIMH NIAMS OBSSR NIBIB NIDCR
|
Jun 22, 2021 |
Jan 8, 2024
|
R01, R21, R43/R44, R41/R42 |
|